市場調査レポート
商品コード
1338248

次世代シーケンサーデータ解析の世界市場 2023-2027

Global Next Generation Sequencing Data Analysis Market 2023-2027

出版日: | 発行: TechNavio | ページ情報: 英文 153 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
次世代シーケンサーデータ解析の世界市場 2023-2027
出版日: 2023年07月05日
発行: TechNavio
ページ情報: 英文 153 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

次世代シーケンサーデータ解析市場は2022-2027年に14億8,874万米ドル、予測期間中のCAGRは21.81%で成長すると予測されています。

当レポートでは、次世代シーケンサーデータ解析市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、個別化医療に対する需要の高まり、遺伝性疾患の早期診断に対する需要の高まり、ゲノミクス研究におけるアプリケーションの拡大によって牽引されています。

本調査では、NGS技術の進歩が、今後数年間の次世代シーケンサーデータ解析市場の成長を促進する主要な理由の1つであると特定しています。また、リアルタイムおよびポイントオブケアNGSデータ解析ソリューションの開発に対する関心の高まりや、クラウドベースのNGSデータ解析ソリューションの採用拡大も、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2022
  • 市場の見通し 2022-2027

第4章 市場規模実績

  • 次世代シーケンサーデータ解析の世界市場 2017-2021
  • エンドユーザーセグメント分析 2017-2021
  • 製品セグメント分析 2017-2021
  • 地域別セグメント分析 2017-2021
  • 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 学術調査:市場規模と予測 2022-2027
  • 臨床調査:市場規模と予測 2022-2027
  • 製薬およびバイオテクノロジー企業:市場規模と予測 2022-2027
  • 病院・診療所など:市場規模と予測 2022-2027
  • 市場機会:エンドユーザー別

第7章 市場セグメンテーション:製品別

  • 市場セグメント
  • 比較:製品別
  • サービス:市場規模と予測 2022-2027
  • NGS商用ソフトウェア:市場規模と予測 2022-2027
  • 市場機会:製品別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2022-2027
  • 欧州:市場規模と予測 2022-2027
  • アジア:市場規模と予測 2022-2027
  • 世界のその他の地域:市場規模と予測 2022-2027
  • 米国:市場規模と予測 2022-2027
  • ドイツ:市場規模と予測 2022-2027
  • カナダ:市場規模と予測 2022-2027
  • 中国:市場規模と予測 2022-2027
  • 英国:市場規模と予測 2022-2027
  • 市場機会:地域情勢別

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Agilent Technologies Inc.
  • Bio Rad Laboratories Inc.
  • Congenica Ltd.
  • DNAnexus Inc.
  • DNASTAR Inc.
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Fabric Genomics Inc.
  • Golden Helix Inc.
  • Illumina Inc.
  • Pacific Biosciences of California Inc.
  • Partek Inc.
  • QIAGEN NV
  • SciGenom Labs Pvt. Ltd.
  • Thermo Fisher Scientific Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on global next generation sequencing data analysis market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by End-user
  • Exhibits33: Data Table on Comparison by End-user
  • Exhibits34: Chart on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Academic research - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Academic research - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Pharma and biotech entities - Market size and forecast 2022-2027 ($ million)
  • Exhibits43: Data Table on Pharma and biotech entities - Market size and forecast 2022-2027 ($ million)
  • Exhibits44: Chart on Pharma and biotech entities - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Pharma and biotech entities - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Chart on Hospitals and clinics and others - Market size and forecast 2022-2027 ($ million)
  • Exhibits47: Data Table on Hospitals and clinics and others - Market size and forecast 2022-2027 ($ million)
  • Exhibits48: Chart on Hospitals and clinics and others - Year-over-year growth 2022-2027 (%)
  • Exhibits49: Data Table on Hospitals and clinics and others - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Market opportunity by End-user ($ million)
  • Exhibits51: Data Table on Market opportunity by End-user ($ million)
  • Exhibits52: Chart on Product - Market share 2022-2027 (%)
  • Exhibits53: Data Table on Product - Market share 2022-2027 (%)
  • Exhibits54: Chart on Comparison by Product
  • Exhibits55: Data Table on Comparison by Product
  • Exhibits56: Chart on Services - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Data Table on Services - Market size and forecast 2022-2027 ($ million)
  • Exhibits58: Chart on Services - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Data Table on Services - Year-over-year growth 2022-2027 (%)
  • Exhibits60: Chart on NGS commercial software - Market size and forecast 2022-2027 ($ million)
  • Exhibits61: Data Table on NGS commercial software - Market size and forecast 2022-2027 ($ million)
  • Exhibits62: Chart on NGS commercial software - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Data Table on NGS commercial software - Year-over-year growth 2022-2027 (%)
  • Exhibits64: Market opportunity by Product ($ million)
  • Exhibits65: Data Table on Market opportunity by Product ($ million)
  • Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits69: Chart on Geographic comparison
  • Exhibits70: Data Table on Geographic comparison
  • Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits107: Market opportunity By Geographical Landscape ($ million)
  • Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits109: Impact of drivers and challenges in 2022 and 2027
  • Exhibits110: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits111: Overview on factors of disruption
  • Exhibits112: Impact of key risks on business
  • Exhibits113: Vendors covered
  • Exhibits114: Matrix on vendor position and classification
  • Exhibits115: Agilent Technologies Inc. - Overview
  • Exhibits116: Agilent Technologies Inc. - Business segments
  • Exhibits117: Agilent Technologies Inc. - Key offerings
  • Exhibits118: Agilent Technologies Inc. - Segment focus
  • Exhibits119: Bio Rad Laboratories Inc. - Overview
  • Exhibits120: Bio Rad Laboratories Inc. - Business segments
  • Exhibits121: Bio Rad Laboratories Inc. - Key news
  • Exhibits122: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits123: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits124: Congenica Ltd. - Overview
  • Exhibits125: Congenica Ltd. - Product / Service
  • Exhibits126: Congenica Ltd. - Key offerings
  • Exhibits127: DNAnexus Inc. - Overview
  • Exhibits128: DNAnexus Inc. - Product / Service
  • Exhibits129: DNAnexus Inc. - Key offerings
  • Exhibits130: DNASTAR Inc. - Overview
  • Exhibits131: DNASTAR Inc. - Product / Service
  • Exhibits132: DNASTAR Inc. - Key offerings
  • Exhibits133: Eurofins Scientific SE - Overview
  • Exhibits134: Eurofins Scientific SE - Business segments
  • Exhibits135: Eurofins Scientific SE - Key news
  • Exhibits136: Eurofins Scientific SE - Key offerings
  • Exhibits137: Eurofins Scientific SE - Segment focus
  • Exhibits138: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits139: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits140: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits141: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits142: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits143: Fabric Genomics Inc. - Overview
  • Exhibits144: Fabric Genomics Inc. - Product / Service
  • Exhibits145: Fabric Genomics Inc. - Key offerings
  • Exhibits146: Golden Helix Inc. - Overview
  • Exhibits147: Golden Helix Inc. - Product / Service
  • Exhibits148: Golden Helix Inc. - Key offerings
  • Exhibits149: Illumina Inc. - Overview
  • Exhibits150: Illumina Inc. - Business segments
  • Exhibits151: Illumina Inc. - Key news
  • Exhibits152: Illumina Inc. - Key offerings
  • Exhibits153: Illumina Inc. - Segment focus
  • Exhibits154: Pacific Biosciences of California Inc. - Overview
  • Exhibits155: Pacific Biosciences of California Inc. - Product / Service
  • Exhibits156: Pacific Biosciences of California Inc. - Key offerings
  • Exhibits157: Partek Inc. - Overview
  • Exhibits158: Partek Inc. - Product / Service
  • Exhibits159: Partek Inc. - Key offerings
  • Exhibits160: QIAGEN NV - Overview
  • Exhibits161: QIAGEN NV - Product / Service
  • Exhibits162: QIAGEN NV - Key news
  • Exhibits163: QIAGEN NV - Key offerings
  • Exhibits164: SciGenom Labs Pvt. Ltd. - Overview
  • Exhibits165: SciGenom Labs Pvt. Ltd. - Product / Service
  • Exhibits166: SciGenom Labs Pvt. Ltd. - Key offerings
  • Exhibits167: Thermo Fisher Scientific Inc. - Overview
  • Exhibits168: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits169: Thermo Fisher Scientific Inc. - Key news
  • Exhibits170: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits171: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits172: Inclusions checklist
  • Exhibits173: Exclusions checklist
  • Exhibits174: Currency conversion rates for US$
  • Exhibits175: Research methodology
  • Exhibits176: Validation techniques employed for market sizing
  • Exhibits177: Information sources
  • Exhibits178: List of abbreviations
目次
Product Code: IRTNTR75844

The next generation sequencing data analysis market is forecasted to grow by USD 1488.74 mn during 2022-2027, accelerating at a CAGR of 21.81% during the forecast period. The report on the next generation sequencing data analysis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for personalized medicine, growing demand for early diagnosis of genetic disorders, and growing applications in genomics research.

Technavio's next generation sequencing data analysis market is segmented as below:

By End-user

  • Academic research
  • Clinical research
  • Pharma and biotech entities
  • Hospitals and clinics and others

By Product

  • Services
  • NGS commercial software

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing advances in NGS techniques as one of the prime reasons driving the next generation sequencing data analysis market growth during the next few years. Also, growing interest in developing real-time and point-of-care NGS data analysis solutions and growing adoption of cloud-based NGS data analysis solutions will lead to sizable demand in the market.

The report on the next generation sequencing data analysis market covers the following areas:

  • Next generation sequencing data analysis market sizing
  • Next generation sequencing data analysis market forecast
  • Next generation sequencing data analysis market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading next generation sequencing data analysis market vendors that include Agilent Technologies Inc., Alphabet Inc., Bio Rad Laboratories Inc., Bionivid Technology Pvt. Ltd., Congenica Ltd., DNAnexus Inc., DNASTAR Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Fabric Genomics Inc., Golden Helix Inc., HiberCell Inc., Illumina Inc., Pacific Biosciences of California Inc., Partek Inc., PierianDx Inc., QIAGEN NV, SciGenom Labs Pvt. Ltd., Takara Bio Inc., and Thermo Fisher Scientific Inc.. Also, the next generation sequencing data analysis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global next generation sequencing data analysis market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global next generation sequencing data analysis market 2017 - 2021 ($ million)
  • 4.2 End-user Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • 4.3 Product Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Academic research - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Academic research - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Academic research - Year-over-year growth 2022-2027 (%)
  • 6.4 Clinical research - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
  • 6.5 Pharma and biotech entities - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Pharma and biotech entities - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Pharma and biotech entities - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Pharma and biotech entities - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Pharma and biotech entities - Year-over-year growth 2022-2027 (%)
  • 6.6 Hospitals and clinics and others - Market size and forecast 2022-2027
  • Exhibit 46: Chart on Hospitals and clinics and others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 47: Data Table on Hospitals and clinics and others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Chart on Hospitals and clinics and others - Year-over-year growth 2022-2027 (%)
  • Exhibit 49: Data Table on Hospitals and clinics and others - Year-over-year growth 2022-2027 (%)
  • 6.7 Market opportunity by End-user
  • Exhibit 50: Market opportunity by End-user ($ million)
  • Exhibit 51: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
  • Exhibit 52: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 53: Data Table on Product - Market share 2022-2027 (%)
  • 7.2 Comparison by Product
  • Exhibit 54: Chart on Comparison by Product
  • Exhibit 55: Data Table on Comparison by Product
  • 7.3 Services - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Services - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on Services - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on Services - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Services - Year-over-year growth 2022-2027 (%)
  • 7.4 NGS commercial software - Market size and forecast 2022-2027
  • Exhibit 60: Chart on NGS commercial software - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Data Table on NGS commercial software - Market size and forecast 2022-2027 ($ million)
  • Exhibit 62: Chart on NGS commercial software - Year-over-year growth 2022-2027 (%)
  • Exhibit 63: Data Table on NGS commercial software - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Product
  • Exhibit 64: Market opportunity by Product ($ million)
  • Exhibit 65: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 69: Chart on Geographic comparison
  • Exhibit 70: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 Canada - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.10 China - Market size and forecast 2022-2027
  • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.11 UK - Market size and forecast 2022-2027
  • Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 107: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 112: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 113: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification
  • 12.3 Agilent Technologies Inc.
  • Exhibit 115: Agilent Technologies Inc. - Overview
  • Exhibit 116: Agilent Technologies Inc. - Business segments
  • Exhibit 117: Agilent Technologies Inc. - Key offerings
  • Exhibit 118: Agilent Technologies Inc. - Segment focus
  • 12.4 Bio Rad Laboratories Inc.
  • Exhibit 119: Bio Rad Laboratories Inc. - Overview
  • Exhibit 120: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 121: Bio Rad Laboratories Inc. - Key news
  • Exhibit 122: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 123: Bio Rad Laboratories Inc. - Segment focus
  • 12.5 Congenica Ltd.
  • Exhibit 124: Congenica Ltd. - Overview
  • Exhibit 125: Congenica Ltd. - Product / Service
  • Exhibit 126: Congenica Ltd. - Key offerings
  • 12.6 DNAnexus Inc.
  • Exhibit 127: DNAnexus Inc. - Overview
  • Exhibit 128: DNAnexus Inc. - Product / Service
  • Exhibit 129: DNAnexus Inc. - Key offerings
  • 12.7 DNASTAR Inc.
  • Exhibit 130: DNASTAR Inc. - Overview
  • Exhibit 131: DNASTAR Inc. - Product / Service
  • Exhibit 132: DNASTAR Inc. - Key offerings
  • 12.8 Eurofins Scientific SE
  • Exhibit 133: Eurofins Scientific SE - Overview
  • Exhibit 134: Eurofins Scientific SE - Business segments
  • Exhibit 135: Eurofins Scientific SE - Key news
  • Exhibit 136: Eurofins Scientific SE - Key offerings
  • Exhibit 137: Eurofins Scientific SE - Segment focus
  • 12.9 F. Hoffmann La Roche Ltd.
  • Exhibit 138: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 139: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 140: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 141: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 142: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.10 Fabric Genomics Inc.
  • Exhibit 143: Fabric Genomics Inc. - Overview
  • Exhibit 144: Fabric Genomics Inc. - Product / Service
  • Exhibit 145: Fabric Genomics Inc. - Key offerings
  • 12.11 Golden Helix Inc.
  • Exhibit 146: Golden Helix Inc. - Overview
  • Exhibit 147: Golden Helix Inc. - Product / Service
  • Exhibit 148: Golden Helix Inc. - Key offerings
  • 12.12 Illumina Inc.
  • Exhibit 149: Illumina Inc. - Overview
  • Exhibit 150: Illumina Inc. - Business segments
  • Exhibit 151: Illumina Inc. - Key news
  • Exhibit 152: Illumina Inc. - Key offerings
  • Exhibit 153: Illumina Inc. - Segment focus
  • 12.13 Pacific Biosciences of California Inc.
  • Exhibit 154: Pacific Biosciences of California Inc. - Overview
  • Exhibit 155: Pacific Biosciences of California Inc. - Product / Service
  • Exhibit 156: Pacific Biosciences of California Inc. - Key offerings
  • 12.14 Partek Inc.
  • Exhibit 157: Partek Inc. - Overview
  • Exhibit 158: Partek Inc. - Product / Service
  • Exhibit 159: Partek Inc. - Key offerings
  • 12.15 QIAGEN NV
  • Exhibit 160: QIAGEN NV - Overview
  • Exhibit 161: QIAGEN NV - Product / Service
  • Exhibit 162: QIAGEN NV - Key news
  • Exhibit 163: QIAGEN NV - Key offerings
  • 12.16 SciGenom Labs Pvt. Ltd.
  • Exhibit 164: SciGenom Labs Pvt. Ltd. - Overview
  • Exhibit 165: SciGenom Labs Pvt. Ltd. - Product / Service
  • Exhibit 166: SciGenom Labs Pvt. Ltd. - Key offerings
  • 12.17 Thermo Fisher Scientific Inc.
  • Exhibit 167: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 168: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 169: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 172: Inclusions checklist
  • Exhibit 173: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 174: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 175: Research methodology
  • Exhibit 176: Validation techniques employed for market sizing
  • Exhibit 177: Information sources
  • 13.5 List of abbreviations
  • Exhibit 178: List of abbreviations